Validation of the International Myeloma Working Group standard response criteria in the PETHEMA/GEM2012MENOS65 study: are these times of change?

Blood(2021)

引用 21|浏览12
暂无评分
摘要
Key Points Depth of standard response criteria after treatment intensification has limited prognostic value in transplant-eligible MM patients Persistence of MRD before maintenance eliminates survival differences across transplant-eligible MM patients in sCR, CR, VGPR and even PR
更多
查看译文
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要